News Review: Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) to Present New Data for JATENZO (testosterone undecanoate) at the Androgen Society 4th Annual Meeting
On Wednesday, Shares of Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) rose 43.45% to $2.08. The stock recorded $1.7200 as its minimum price and hit the max level of $3.9400, during …
News Review: Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) to Present New Data for JATENZO (testosterone undecanoate) at the Androgen Society 4th Annual Meeting Read More